IPO registrations (S-1, F-1) · Registrants

Pluri Inc.

SEC CIK
1158780 · filings on EDGAR ↗
Former names
PLURISTEM THERAPEUTICS INC (2008–2022); PLURISTEM LIFE SYSTEMS INC (2003–2007); AI SOFTWARE INC (2001–2003)
Registration
Form S-1, first filed 2026-10-06; 1 initial registration, 0 amendments
Outcome
Declared effective 2026-10-15
Industry (SIC)
Biological Products, (No Diagnostic Substances) 2836
Incorporated in
NV
Business address
MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, Haifa
EIN
98-0351734
Ticker
PLUR (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Pluri Inc. on the corporate pages

Offering terms

Shares offered
2,228,940
Listing
Nasdaq under the symbol PLUR

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 2

FiledFormWhat it isName as filedEDGAR
2026-10-06S-1S-1 (registration)Pluri Inc.0001213900-26-107182 ↗
2026-10-15EFFECTEFFECT (declared effective)Pluri Inc.9999999995-26-003262 ↗

Prospectus pages read 1

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2026-10-06S-1registration statement$1.502,228,940$3,343,410Nasdaq PLUR0primary document; price sentence, shares headline, proceeds computeddocument ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Aberman ZamiDirector; Director,OfficerCEO & Chairman; CEO & Co. Chairman; Co-CEO & Chairman; Executive Chairman; President and CEO432006–2025
Keret YossiOfficerChief Financial Officer12006
BEN-YORAM ISRAELDirector312006–2019
BRAUN ISAACDirector212006–2020
MERETSKI SHAITenPercentOwner12006
MERETZKI HAVADirector192006–2018
SHORRER DORONDirector262006–2026
YANAY YAKYDirector,Officer; OfficerCEO & President; CFO; CFO, COO & President; CFO, Executive Vice President; Chief Executive Officer; Chief Financial Officer; Co-CEO & President; COO, CFO & President; COO & President; President, COO, CFO452007–2025
GERMAIN MARKDirector242007–2020
Doyle Michael C.TenPercentOwner22007
Wood River TrustTenPercentOwner22007
ROSMAN NACHUMDirector232007–2018
Pines ShaiDirector92008–2011
Kwiat MoriaDirector112012–2020
Gur-Lavie BoazOfficerCFO; Chief Financial Officer52014–2015
Egozi ErezOfficerChief Financial Officer42017–2018
Franco-Yehuda ChenOfficerChief Financial Officer52019–2024
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPTenPercentOwner172020–2021
Shemesh-Rasmussen MaitalDirector52021–2025
Levi Rami AvrahamDirector52021–2025
Birger Pinhas DoronDirector42021–2025
Shalev VardaDirector22021
Abony Lorne KennethDirector32023–2024
Zalts LiatOfficerChief Financial Officer32024–2025
Chutzpah Holdings LtdDirector; Director,TenPercentOwner; TenPercentOwner62025–2026
Manieu Alexandre WeinsteinDirector,TenPercentOwner; TenPercentOwner92025–2026
Ajchenbaum EitanDirector32025

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2026-09-04Pluri Inc.Biotechnology$3,677,751$3,677,75111
2025-03-19Pluri Inc.Biotechnology$3,500,000$3,500,00011
2022-12-30Pluri Inc.Biotechnology$8,469,323$8,469,323141

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerPluri Inc.Form D private offeringsCIK (EXACT)
SEC filerPluri Inc.SEC filers (EDGAR)CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances):

More with this interest.

Interests: Biological Products, (No Diagnostic Substances) · Health